Dimed S.A. Distribuidora de Medicamentos Stocks

R$ 14.4Last Updated 31.03.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

R$ 399.71M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
R$ 14.4
Key Takeaways

Risk factor

Modest price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermocosmetics in Brazil. It operates in Retail and Wholesale segments. The company offers products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo. It operates 517 stores in Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. The company was formerly known as Panvel S.A. Drogarias e Farmacias and changed its name to Dimed S.A. Distribuidora de Medicamentos in April 2000. The company is headquartered in Eldorado do Sul, Brazil.

Company Valuation

Undervalued
6/7

Based on key historical and expected multiples, the stock is undervalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'cheap' on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of PNVL3.SA is 12 and suggests 18% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks